GO
Loading...

Enter multiple symbols separated by commas

Endo Health Solutions Inc

More

  • US STOCKS-Wall St futures rise as euro recovers Monday, 16 Mar 2015 | 9:02 AM ET

    *Empire State manufacturing data miss estimates. March 16- U.S. stock index futures were up on Monday, putting the benchmark S&P 500 on track for a rebound after three weeks of losses, as currency markets helped reassure U.S. investors concerned about how a strong dollar would hurt earnings. A recovery in the euro was reassuring investors as a rapidly rising U.S....

  • BUZZ-SALIX PHARMACEUTICALS PLC: VALEANT RAISES ALL-CASH OFFER@** American drugmaker's shares up 2 pct at $173. **Canadian drugmaker Valeant Pharmaceuticals International Inc raised its offer to buy Salix to $173 from $158 in cash. **Sources told Reuters on Friday Valeant was working with its top shareholders on plans to raise its offer for Salix, sending Dublin-...

  • March 12- Endo International Plc's $11 billion offer this week for Salix Pharmaceuticals Ltd, an effort to trump an agreed $10 billion bid from Valeant Pharmaceutical Inc, illustrates CEO Rajiv De Silva's plan to be seen as not just a protege of Valeant chief Mike Pearson, but as a challenger. If successful, buying Raleigh, North Carolina- based Salix would combine...

  • The number of men being prescribed testosterone jumped more than 75 percent, to 2.3 million, between 2009 and 2013. About 70 percent of these patients were between the ages of 40 and 64, the FDA said. AbbVie Inc's AndroGel, one of the most widely-used products, raked in sales of $934 million in 2014. Other products include Endo International Plc's Testim and Eli...

  • *Markit manufacturing hits 4- month high. NEW YORK, March 2- U.S. stocks advanced on Monday, with the Nasdaq nudging above the 5,000 mark for the first time in 15 years, as a round of mixed data pointed to a slowly accelerating economy. Fundamentals are good enough at technology companies, the biggest group on Nasdaq, that the index should be able to stay above 5000, said...

  • *Markit manufacturing hits 4- month high, ISM hits 13- month low. NEW YORK, March 2- U.S. stocks advanced on Monday to push the Nasdaq above the 5,000 mark for the first time in fifteen years, as a round of mixed data pointed to a slowly accelerating economy. "Five thousand on the Nasdaq, it's been a long time coming," said Peter Kenny, chief market strategist at Clearpool...

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *Investors will also eye data on the manufacturing sector, with financial data firm Markit final Manufacturing Purchasing Managers Index expected at 9:45 a.m.. The Institute for Supply Management's reading on the manufacturing sector is scheduled for release at 10:00 a.m..

  • NEW YORK, Feb 20- Valeant Pharmaceuticals International Inc is close to a deal to acquire bowel drug maker Salix Pharmaceuticals Ltd for around $160 per share, according to a person directly familiar with the matter. A deal of that size would be the largest ever for Valeant, which lost a takeover contest for Allergan Inc last year. The usually acquisitive Valeant...

  • Jan 26- The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. Nexium raked in about $1.9 billion in global sales in the first half of 2014, according to AstraZeneca's latest earnings statement.

  • After-Hours Buzz: CSTR, PRGS & More Thursday, 3 Jan 2013 | 4:39 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Thursday:

  • After-Hours Buzz: Juniper, Boston Beer & More Wednesday, 12 Dec 2012 | 5:42 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Wednesday.

  • Why Samsung Stock Surge Won’t Fizzle Out Like Apple’s

    Shares of Samsung Electronics, which have surged almost 35 percent since the start of the year, closed at an all-time high on Thursday boosted by expectations that its smartphone business will continue to drive strong profit growth.

  • Here Are Small Cap Values: Gabelli Wednesday, 21 Nov 2012 | 1:39 PM ET
    Here Are Small Cap Values: Gabelli

    With bigger companies looking to grow, many may look to acquire smaller firms. That’s one of the reasons Mario Gabelli, chairman of Gamco Investors, sees opportunity in small-cap equities.

  • Oct 11- Endo Health Solutions Inc:. *FDA- became aware of cases of a serious blood disorder in individuals abusing. *FDA says the disorder related to Endo's Opana ER resulted in kidney failure.

  • Opana, a powerful opioid painkiller containing oxymorphone, is produced by Endo Pharmaceuticals. The blood disorder, thrombotic thrombocytopenic purpura, resulted in kidney failure requiring dialysis in some cases and at least one death, the Food and Drug Administration said.

  • Abuse of painkiller Opana can cause blood disorder-US FDA Thursday, 11 Oct 2012 | 12:12 AM ET

    Opana is produced by Endo Pharmaceuticals. The blood disorder, thrombotic thrombocytopenic purpura, resulted in kidney failure requiring dialysis in some cases, and at least one death, the Food and Drug Administration said. The FDA said problems appear to occur with Opana ER only when it is abused and injected intravenously.

  • Oct 9- Endo Health Solutions Inc:. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

  • Oct 5- Endo Health Solutions Inc:. *Oppenheimer cuts Endo Health Solutions Inc price target to $42 from. Reuters Station users, click. 1568.